Transcriptome Analyses of Adipose Tissue Samples Identify EGFL6 as a Candidate Gene Involved in Obesity-Related

Kathrin Landgraf1, Andreas Kühnapfel2, Maria Schlanstein1

  • 1Center for Pediatric Research Leipzig (CPL), Hospital for Children & Adolescents, Leipzig University, 04103 Leipzig, Germany.

Insights

Childhood obesity shows early adipose tissue dysfunction. Gene expression changes, particularly involving EGFL6, are linked to metabolic disease development in children.

Area of Science:

  • Molecular biology
  • Pediatric endocrinology
  • Metabolic disease research

Background:

  • Childhood obesity is linked to early adipose tissue (AT) dysfunction and metabolic disease.
  • Understanding molecular changes in pediatric AT is crucial for early intervention.

Purpose of the Study:

  • To investigate genome-wide gene expression profiles in pediatric adipose tissue (AT) during obesity.
  • To identify molecular pathways and specific genes associated with AT dysfunction and metabolic disease in children.

Main Methods:

  • Analysis of genome-wide expression profiles in AT samples, isolated adipocytes, and stromal vascular fraction (SVF) cells from children.
  • Assessment of gene expression in relation to obesity parameters (BMI SDS, adipocyte size, macrophage infiltration, adiponectin, leptin).
  • In vitro studies of epidermal growth factor-like protein 6 (EGFL6) during adipocyte differentiation and correlation analysis in children.

Main Results:

  • Obesity in children is associated with altered gene expression in AT, adipocytes, and SVF cells.
  • Metabolic and extracellular structural pathways were enriched in AT and adipocytes, while SVF cells showed enrichment in inflammatory pathways.
  • EGFL6 expression in adipocytes positively correlated with adipocyte hypertrophy, AT dysfunction markers (macrophage infiltration, hs-CRP, leptin), and insulin resistance (HOMA-IR).

Conclusions:

  • Early alterations in gene expression within adipose tissue are associated with AT dysfunction in children.
  • EGFL6 is identified as a potential key player in the pathogenesis of childhood obesity-related metabolic disease.